(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 17.18% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.59%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Axogen's revenue in 2026 is $251,174,000.On average, 11 Wall Street analysts forecast AXGN's revenue for 2026 to be $15,328,482,587, with the lowest AXGN revenue forecast at $14,699,472,884, and the highest AXGN revenue forecast at $15,845,668,342. On average, 11 Wall Street analysts forecast AXGN's revenue for 2027 to be $18,160,101,476, with the lowest AXGN revenue forecast at $16,906,920,608, and the highest AXGN revenue forecast at $19,224,579,434.
In 2028, AXGN is forecast to generate $21,961,578,061 in revenue, with the lowest revenue forecast at $20,168,093,987 and the highest revenue forecast at $23,355,614,093.